Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Share-based Compensation: 2016-2024

Historic Share-based Compensation for Solid Biosciences (SLDB) over the last 9 years, with Dec 2024 value amounting to $10.5 million.

  • Solid Biosciences' Share-based Compensation rose 97.16% to $3.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.5 million, marking a year-over-year increase of 37.95%. This contributed to the annual value of $10.5 million for FY2024, which is 37.95% up from last year.
  • Solid Biosciences' Share-based Compensation amounted to $10.5 million in FY2024, which was up 37.95% from $7.6 million recorded in FY2023.
  • In the past 5 years, Solid Biosciences' Share-based Compensation ranged from a high of $13.4 million in FY2021 and a low of $7.5 million during FY2022.
  • Its 3-year average for Share-based Compensation is $8.6 million, with a median of $7.6 million in 2023.
  • Its Share-based Compensation has fluctuated over the past 5 years, first tumbled by 43.64% in 2022, then soared by 37.95% in 2024.
  • Yearly analysis of 5 years shows Solid Biosciences' Share-based Compensation stood at $11.6 million in 2020, then rose by 15.00% to $13.4 million in 2021, then slumped by 43.64% to $7.5 million in 2022, then climbed by 1.17% to $7.6 million in 2023, then surged by 37.95% to $10.5 million in 2024.